EUVIMEDEUVIMED entdecken
Crossref

A Biomimetic Autophagosomes‐Based Nanovaccine Boosts Anticancer Immunity

Liping Qu, Guanhong Cui, Yinping Sun, Ruonan Ye, Yu Sun, Fenghua Meng, Shenqiang Wang iD, Zhiyuan Zhong iD

Advanced Materials · 2024-10 · 36 (40)

DOI: 10.1002/adma.202409590 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 28.08.2024. Verfasst von Liping Qu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, and State Key Laboratory of Radiation Medicine and …. Hauptthemen laut MEDLINE: Cancer Vaccines, Biomimetic Materials, Autophagosomes. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Key R&D Program of China, Startup Packages of Soochow University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Personalized cancer vaccines based on tumor cell lysates offer promise for cancer immunotherapy yet fail to elicit a robust therapeutic effect due to the weak immunogenicity of tumor antigens. Autophagosomes, obtained from pleural effusions and ascites of cancer patients, have been identified as abundant reservoirs of tumor neoantigens that exhibit heightened immunogenicity. However, their potential as personalized cancer vaccines have been constrained by suboptimal lymphatic‐targeting performances and challenges in antigen‐presenting cell endocytosis. Here,a reinforced biomimetic autophagosome‐based (BAPs) nanovaccine generated by precisely amalgamating autophagosome‐derived neoantigens and two types of adjuvants capable of targeting lymph nodes is developed to potently elicit antitumor immunity. The redox‐responsive BAPs facilitate cytosolic vaccine opening within antigen‐presenting cells, thereby exposing adjuvants and antigens to stimulate a strong immune response. BAPs evoke broad‐spectrum T‐cell responses, culminating in the effective eradication of 71.4% of established tumors. Notably, BAPs vaccination triggers enduring T‐cell responses that confer robust protection, with 100% of mice shielded against tumor rechallenge and a significant reduction in tumor incidence by 87.5%. Furthermore, BAPs synergize with checkpoint blockade therapy to inhibit tumor growth in the poorly immunogenic breast cancer model. The biomimetic approach presents a powerful nanovaccine formula with high versatility for personalized cancer immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer VaccinesBiomimetic MaterialsAutophagosomesAnimalsMiceCell Line, TumorHumansImmunotherapyFemaleAntigens, NeoplasmNanoparticlesAdjuvants, ImmunologicBiomimeticsNanovaccines

Stichwörter der Autor:innen

antigen cross‐presentationautophagosomecancer vaccineimmunotherapylymphatic delivery

Substanzen

Cancer VaccinesAntigens, NeoplasmAdjuvants, ImmunologicNanovaccines

Autor:innen und Institutionen

  • Biomedical Polymers Laboratory, College of Chemistry, Chemical Engineering and Materials Science, and State Key Laboratory of Radiation Medicine and Protection, Soochow University, Suzhou, 215123, P. R. China.
  • College of Pharmaceutical Sciences, Soochow University, Suzhou, 215123, P. R. China.

ORCID-Profile: Shenqiang Wang, Zhiyuan Zhong

Förderung

  • National Natural Science Foundation of China
  • National Key R&D Program of China
  • Startup Packages of Soochow University
  • National Key Research and Development Program of China

Zitieren

APA

Qu, L., Cui, G., Sun, Y., Ye, R., Sun, Y., Meng, F., Wang, S., & Zhong, Z. (2024). A Biomimetic Autophagosomes‐Based Nanovaccine Boosts Anticancer Immunity. Advanced Materials, 36(40). https://doi.org/10.1002/adma.202409590

Vancouver

Qu L, Cui G, Sun Y, Ye R, Sun Y, Meng F, et al. A Biomimetic Autophagosomes‐Based Nanovaccine Boosts Anticancer Immunity. Advanced Materials. 2024;36(40). doi:10.1002/adma.202409590

BibTeX
@article{Qu2024,
  author = {Qu, Liping and Cui, Guanhong and Sun, Yinping and Ye, Ruonan and Sun, Yu and Meng, Fenghua and Wang, Shenqiang and Zhong, Zhiyuan},
  title = {A Biomimetic Autophagosomes‐Based Nanovaccine Boosts Anticancer Immunity},
  journal = {Advanced Materials},
  year = {2024},
  volume = {36},
  number = {40},
  doi = {10.1002/adma.202409590}
}
Kostenlos starten →